A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer

Part of paid clinical trials in Kansas City, Kansas.

Sponsor
Children's Hospital Medical Center, Cincinnati
Study ID
NCT07223463
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Cancer
  • Medication Adherence

Eligibility Criteria

Sex
ALL
Age
15 Years - 24 Years
Healthy Volunteers
Not accepted

Interventions

  • Tailored Program — BEHAVIORAL
    Participants will participate in 4 sessions with a coach, 1 every other week. During these sessions, the participant will work with their coach to identify a barrier to adherence they would like to target. Then, they will work with their coach to create an action plan using evidence-based behavior change techniques to address this barrier. In between sessions (on alternating weeks), the coach will check-in with a text reminder about the plan.
  • Feedback Program (Uniform Standard of Care) — BEHAVIORAL
    Participants will receive weekly text messages with feedback about their adherence and guidance for requesting additional support if desired

Study Details

The goal of this clinical trial is to learn if a tailored intervention can help make it easier for adolescents and young adults with cancer to take their medications. The main questions the researchers are trying to answer are: * Does the tailored intervention increase adherence? * Does the tailored intervention improve quality of life? * Does the tailored intervention reduce health care utilization? The researchers will compare the tailored intervention to a uniform standard of care intervention (an intervention designed to be similar to what is currently happening in clinical care) to see if the tailored intervention works to improve adherence. Participants will: * Use an electronic pill bottle or box to store their medication * Participate in intervention sessions * Complete surveys before the intervention, after the intervention, and 6-months later

Key Dates

Start date
Mar 31, 2026
Status verified
Oct 2025
Primary completion
Jan 31, 2030
Completion
Aug 31, 2030

Study Design

Enrollment
160 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Tailored Program
    8-week program including 4 coach visits and 4 text check-ins
  • Other: Feedback Program (Uniform Standard of Care)
    8-week feedback program including weekly texts

Primary Outcome Measure

Medication Adherence [ Time Frame: The 1-month period following the completion of one of the study programs. ]

Central Contacts

Locations (4)

FacilityCityStateZIPSite coordinators
The University of Kansas Medical CenterKansas CityKansas66160
Carolyn Bates, PhD
[email protected]
Columbia University Irving Medical CenterNew YorkNew York1003230702
Melissa Beauchemin, PhD
[email protected]
Cincinnati Children's Hospital Medical CenterCincinnatiOhio45229-
Seattle Children's HospitalSeattleWashington98105-

Find similar trials in Kansas City, KS

By research site
The University of Kansas Medical Center· Kansas City, KSColumbia University Irving Medical Center· New York, NYCincinnati Children's Hospital Medical Center· Cincinnati, OHSeattle Children's Hospital· Seattle, WA

Related Studies